PET Scan vs. MRI: What’s the Difference?
Both PET scans and MRI are beneficial medical imaging techniques, but they each have particular benefits and drawbacks. While MRI is particularly useful for creating detailed images of the body’s soft tissues and has the ability to image the body in multiple planes, PET scans are particularly useful for providing functional information about the body’s tissues and organs and are highly sensitive and accurate. The most thorough and precise diagnosis and treatment plan may every once in a while, be produced by combining PET and MRI.
Lung cancer screening programs are catching more disease while still curable
Story: https://www.healio.com/news/hematology-oncology/20221212/lung-cancer-screening-leads-to-more-stage-i-less-stage-iv-disease-incidence Implementation of lung cancer screening across five diverse health care systems led to higher rates of stage I diagnoses and lower rates of stage IV disease, study results showed. Overall incidence of lung cancer did not increase during the study period, indicating a limited impact of overdiagnosis, according to the findings published in Journal […]
Patient calls nuclear medicine treatment “a beam of light”
Story: https://www.nbcboston.com/news/local/dont-give-up-hope-man-describes-cutting-edge-cancer-treatment/2830563/ ‘Don’t Give Up Hope’: Man Describes Cutting-Edge Cancer Treatment Paul Bristow was the first patient at Dana Farber Cancer Institute in Boston to undergo a new nuclear medicine treatment for his metastatic prostate cancer Paul Bristow loves being active. So when the 69-year-old was diagnosed with metastatic prostate cancer, it came as a […]
Lutetium PSMA targeted radiotherapy for prostate cancer
Article: https://www.cancernetwork.com/view/phillip-h-kuo-md-phd-reviews-rationale-of-phase-3-vision-trial-of-117lu-psma-617-in-mcrpc At the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, CancerNetwork® spoke with Phillip H. Kuo, MD, PhD, professor of medical imaging, biomedical engineering, and medicine as well as member of the Graduate Faculty at The University of Arizona College of Medicine in Tucson, about the rationale behind the phase 3 VISION trial (NCT03511664) […]
Advantages of PSMA-PET imaging in prostate cancer care
Article: https://healthimaging.com/topics/medical-imaging/nuclear-medicine/video-advantages-psma-pet-imaging-prostate-cancer-care Munir Ghesani, MD, FACNM, FACR, president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, and associate professor of radiology at Icahn School of Medicine at Mount Sinai, explains prostate-specific membrane antigen (PSMA) targeted radiotracers used in positron emission tomography (PET) scans are seeing rising […]
68Ga-PSMA PET/CT Protocols May Differ for RP, BCR
Article: https://www.docwirenews.com/gu-oncology-now/gu-psma-knowledge-hub/68ga-psma-pet-ct-protocols-may-differ-for-rp-bcr/ New Research on Persisting PSA after Prostatectomy Suggests PSMA PET New research suggests that men with PSA level persistence after undergoing radical prostatectomy (RP) should be recommended 68Ga-PSMA PET scans even if their PSA level is considered low. Whereas patients with biochemically recurrent (BCR) prostate cancer after RP should be monitored based on their […]
PSMA PET/CT Lymph Node Staging Can Predict Prostate Cancer Surgery Outcomes
Article: https://www.renalandurologynews.com/home/news/urology/prostate-cancer/psma-pet-ct-lymph-node-staging-can-predict-prostate-cancer-surgery-outcomes/ Patients with prostate cancer who have pelvic lymph node metastases visualized on preoperative PSMA PET/CT staging (prostate-specific membrane antigen positron emission tomography/computed tomography) have a significantly higher risk for biochemical disease progression after robot-assisted radical prostatectomy (RARP) compared with those without pelvic lymph node metastases on imaging, recent study findings suggest. The retrospective […]
PSMA PET/CT may improve recurrent prostate cancer detection
Article: https://medicalxpress.com/news/2022-09-psma-petct-imaging-prostate-cancer.html Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients by Society of Nuclear Medicine and Molecular Imaging In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with 18F-DCFPyL PSMA PET/CT has been shown to considerably improve detection of active disease as compared to imaging with CT […]
PSA & PET Features to Select sLND Persons in Recurrent PCa
Article: https://www.physiciansweekly.com/psa-pet-features-to-select-slnd-persons-in-recurrent-pca For a study, researchers sought to assess the association between pre-operative PSA value, 68Ga-prostate-specific-membrane-antigen (PSMA) PET performance, and oncologic results following salvage lymph node dissection (sLND) for biochemical recurrent prostate cancer (PCa). In the analysis, 164 patients who had undergone pelvic±retroperitoneal sLND at 11 high-volume centers between 2012 and 2019 and had at least […]
Nearly 30% of US Cancer Deaths Linked to Smoking
Article: https://www.medscape.com/viewarticle/979929?reg=1&icd=ssl_login_success_221019 Nearly 123,000 cancer deaths – or almost 30% of all cancer deaths – in the United States in 2019 were linked to cigarette smoking, a new analysis suggests. That corresponds to more than 2 million person-years of lost life and nearly $21 billion in annual lost earnings. “During the past few decades, smoking has […]